Enter your email address to receive notifications of new posts by email.
RegeneRx Joint Venture Initiates Second Phase 3 Study Of RGN-259 for Dry Eye Syndrome - See more at: https://t.co/1GhlQeRGcCabout 1 hour ago
https://t.co/mlayrzDV99 Athersys’s Therapy Prospect Boosted by FDA $ATHXabout 4 hours ago
Athersys Receives Special Protocol Assessment from FDA for Phase 3 “MASTERS-2” Trial for Ischemic Stroke Treatment https://t.co/JU7ZefcAnN9:15 PM Sep 28th
IsoRay, Inc. Announces Launch of Newly Redesigned Patient and Clinician Focused Corporate Website - See more at: https://t.co/0efxvzg7b75:15 PM Sep 28th
Get every new post delivered right to your inbox.